-
Why Cyclacel Pharmaceuticals (CYCC) Stock Is Skyrocketing
03 Jan 2025 15:31 GMT
Cyclacel Pharmaceuticals Inc CYCC shares are trading … other instrument.
For example, in Cyclacel Pharmaceuticals’ case, it is in the …
-
Cyclacel Pharmaceuticals Announces Agreement for the Acquisition of Preferred Stock by David Lazar
03 Jan 2025 14:01 GMT
… . 03, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … risks described more fully in Cyclacel Pharmaceuticals’ filings with the Securities … IR@cyclacel.com © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cushing's Syndrome Market Poised for Remarkable Growth by 2032 | DelveInsight
06 Feb 2025 15:18 GMT
… include Corcept Therapeutics, Crinetics Pharmaceuticals, Cyclacel Pharmaceuticals, Sparrow Pharmaceuticals, Stero Therapeutics, … : Corcept Therapeutics, Crinetics Pharmaceuticals, Cyclacel Pharmaceuticals, Sparrow Pharmaceuticals, Stero Therapeutics, …
-
Cyclacel Pharmaceuticals Announces Its Exploration of Potential Strategic Alternatives and Reduction of Operating Costs
05 Dec 2024 21:05 GMT
… . 05, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … risks described more fully in Cyclacel Pharmaceuticals’ filings with the Securities … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces Closing of Exercise of Warrants for $2.1 Million Gross Proceeds
14 Nov 2024 21:15 GMT
… . 14, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … state or other jurisdiction. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Announces That Nasdaq Granted an Extension to Regain Compliance With the Equity Standard Rule
24 Oct 2024 13:15 GMT
… . 24, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … to the Hearing Panel. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … or otherwise. Contact
© Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals Reports New Clinical Data from Ongoing, Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium
23 Oct 2024 13:15 GMT
… . 23, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP … 100% (6/6). About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical … , IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
-
Cyclacel Pharmaceuticals to Present New Clinical Data From Phase 2 Study of Oral Fadraciclib at the 2024 EORTC-NCI-AACR Symposium
09 Oct 2024 13:15 GMT
… . 09, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … presentation are listed below: About Cyclacel Pharmaceuticals, Inc. Cyclacel is a … IR@cyclacel.com © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. …
-
Cyclacel Pharmaceuticals Announces Completion of Enrollment in the Biomarker-Enriched Patient Cohort of Its Phase 2 Study
25 Sep 2024 13:15 GMT
… 25, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, … otherwise. Contact © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved … Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. ______________________________
1 www …
-
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
04 Sep 2024 13:15 GMT
… . 04, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: … , New York, NY. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical … or otherwise. Contact © Copyright 2024 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The …
About
© 1995-2025